Toggle Health Problems and D

Cisplatin chemotherapy dose size might be reduced by Omega-3 – Jan 2018

Effect of long-chain omega-3 polyunsaturated fatty acids on cisplatin chemoresistance in murine and human melanoma cells

DOI: 10.1158/1557-3265.TCM17-A56 Published January 2018
Abstracts: AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; São Paulo, Brazil
Renata O. Vasconcelos, Simona Serini, Ana Paula S. Votto, Gilma S. Trindade and Gabriella Calviello


See also web

The incidence of melanoma is continuously growing worldwide, and an effective therapy for the metastatic disease still does not exist. Moreover, an intrinsic/extrinsic resistance to conventional chemotherapeutics, such as cisplatin (CPt), often arises in this tumor. The increased expression of a number of DNA repair genes, including the Excision Repair Cross-Complementation group 1 (ERCC1), has been related to the melanoma resistance to CPt. ERCC1 is a component of an important chemoresistance pathway [tyrosine-phosphatase dual-specificity phosphatase-6 (DUSP6)/extracellular signal-regulated kinase phosphorylation (p-ERK)/ERCC1]. New therapeutic strategies are under study, and one possibility is the administration of natural products combined with CPt therapy, in order to revert the CPt resistance.

Many experimental in vitro and in vivo studies have contributed to support the antineoplastic properties of long-chain omega-3 polyunsaturated fatty acids (LC-omega-3 PUFA), especially docosahexaenoic acid (DHA), in tumor cells of different origin, including melanoma.

In the present work the effects of CPt treatment combined with LC-omega-3 PUFA have been evaluated in highly metastatic murine (B16F10) and human (WM266-4) melanoma cell lines. Melanoma cells were exposed to increasing concentrations of CPt (1, 2.5 and 5 μM), alone or in combination with DHA (10 μM). Cell viability was analysed by the Trypan blue dye exclusion method 24, 48, and 72 h after treatment. The in vitro invasive ability of melanoma cells was assessed by the Wound Healing assay. The effects of increasing DHA concentrations combined or not with CPt on the expression of several proteins (ERCC1, pERK and DUSP6) related to CPt chemoresistance in melanoma cells were also analyzed by Western Bbotting. The data obtained demonstrated that the CPt/DHA combined treatment, performed by adding suboptimal concentrations of both the compounds, was significantly more efficient in inhibiting cell growth than the treatments with each of the two compounds administered alone.
We confirmed that CPt was able to increase ERCC1 and decrease DUSP- 6 in a dose-dependent manner in both WM266-4 and B16F10 cell lines. Moreover, in the present work it was observed that DHA was able to revert the effects of CPt on ERCC1, DUSP6, and p-ERK expression. Similarly to what was observed with DHA, the LC-omega-3 PUFA eicosapentaenoic acid (EPA) exerted similar effects, even though at lower extent, on ERCC1, p-ERK, and DUSP6 expression in the same experimental conditions.

Overall, the findings indicate that the combination of CPt with a dietary supplementation with LC-omega-3 PUFA could potentially represent a new, promising, complementary therapeutic strategy in order to overcome CPt resistance in melanoma.

Created by admin. Last Modification: Saturday January 6, 2018 19:23:39 GMT-0000 by admin. (Version 8)

Attached files

ID Name Comment Uploaded Size Downloads
9144 DHA and cancer treatment.pdf admin 06 Jan, 2018 19:15 1.18 Mb 560
9143 BC chemo Omega-3.pdf admin 06 Jan, 2018 19:06 530.65 Kb 2404
9142 Omega-3 chemo cognitive.pdf admin 06 Jan, 2018 19:00 387.18 Kb 593